Pnina Feldman's Cannabis Stock Queensland Bauxite Clears the Air on Andrew 'Dr Pot' Katelaris Confusion

Twitter icon

A bit of notoriety is good for a medicinal cannabis start-up, but obviously not too much.

Pnina "Diamond Rose" Feldman's well known pot stock, Queensland Bauxite Ltd, had to clear the air on Monday as to the status of an employee at its 55 per cent owned Medical Cannabis Ltd (MCL) – company founder and secretary of the Hemp Party, Andrew Kavasilas

"It has come to our attention that there has been some confusion between Andrew Kavasilas of (MCL) and Andrew Katelaris," said the ASX release.  

Katelaris is the controversial deregistered doctor, known as Dr Pot, who was arrested recently and will face court in a few weeks after being charged with some cannabis-related offences. 

Pnina Feldman has sought to clear up confusion about the two Andrews.

Pnina Feldman has sought to clear up confusion about the two Andrews. Photo: Ben Rushton

"This is not the first time that there has been confusion between Andrew Katelaris and Andrew Kavasilas ... Australia's much-respected authority on medical cannabis," said the statement from Feldman. 

Not that either Andrew would want to cast any stones when it comes to behaviour that might not meet the strict letter of the law.

MCL's Kavasilas was recently quoted in Dope Magazine in his role as one of the organisers of Nimbin's annual MardiGrass festival. 

When asked what he's most looking forward to this year, he mentioned "the joint rolling competition", where previous champion, Bob the Builder, would take on last year's winner, Luke Summ. 

Dr Andrew Katelaris is one of Australia's biggest medicinal cannabis suppliers.

Dr Andrew Katelaris is one of Australia's biggest medicinal cannabis suppliers.  Photo: Rohan Thomson

And do the competitors take the event seriously?

Amazonian 

As our local retailers wait for the great Amazon tsunami to hit our shores, some might be wondering what former Woolworths exec, Greg Foran, has done about the behemoth.

After all, he has been fighting Amazon in its own backyard for the past three years as the CEO of Walmart's US supermarket business. "Technology is driving enormous change in retail and the competition is very fierce," Foran told employees and investors at the week-long party that preceded last Friday's shareholder meeting.

"But we have an advantage that no one else has: all of you, our associates."

He meant this quite literally, given Walmart is now trialling a service where employees are given incentives to deliver packages on their way home from work. 

Keep in mind that Walmart claims to employ 1.5 million "associates" in the US alone.  

And the incentives might work given the report a few years back stating Walmart's lowly paid workers cost US taxpayers $US6.2 billion in assistance including food stamps.

One of Foran's early initiatives was to spend billions giving his employees a pay rise and billions more on the retailer's e-commerce efforts. 

This includes a five-metre high tower, nicknamed Rapunzel, which acts as a vending machine for online purchases. 

But for the most part, Foran has relied on very familiar sounding strategies like fresh food – wonder where he got that one from? – and cutting prices to narrow the gap with Aldi. 

Online sales have grown strongly and earnings are actually heading in the right direction. So, what has that done for investors? 

Walmart shares are now worth slightly more than when Foran joined in 2014, while Amazon shares have nearly tripled in value over the past two years to the point it is now worth double Walmart's market cap. 

That's Gould 

Before pharmaceutical group Cyclopharm announced its $7 million capital raising on Monday, one of its directors was pulled up by the ASX cops for some untidy paperwork. 

It's the sort of thing that can happen to any director of a listed entity.

You've got shares in all sorts of corporate vehicles, and it can get really hard to keep track of.

Especially when you have to account for an interest in Cyclopharm stock, which you don't actually own, due to the fact that you act as an advisor to the entities, which hold the stock. 

And then they sell their shares, and it's not like you will get informed in a timely manner. 

Which is why the ASX cops pinged the rather unfortunate Vanda Russell Gould last week for his tardy change of director's interest notice. 

The former high-flying Sydney accountant has a lot on his plate after he was found by the High Court last November to have avoided paying tax in a case the Tax Office described as "blatant tax evasion".  

"Oh yeah, Luke trains all year. Full hemp diet. He's a true athlete. You can pick any drug test you like, he'd fail them all," Kavasilas told the paper. 

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Article category: 
Regional Marijuana News: